The objective of our University of Washington?s (UW) Pediatric Infectious Diseases (PID) Training Program (TP) is to train future leaders in research on infectious diseases of children. Our TP (1) recruits experienced and committed pediatricians; (2) trains them in basic and novel molecular, genomic, proteomic, bioinformatic, and epidemiologic methods, and (3) mentors them to develop and lead an independent research program. We request the renewal of T32 support to train four pediatricians in research annually. Initially, each fellow engages in 12 months of clinical training (for PID certification), supported by Seattle Children's Hospital (SCH). Subsequently, the T32 will support 2 years of mentored research by Training Faculty (TF) who are leaders in their areas of research and excel at mentorship. Trainees and TF are encouraged to tackle projects that will contribute novel and critical insights into understanding and treating pediatric infectious diseases and generate preliminary data for a K, R, or other award. In addition, fellows receive didactic and hands-on education in the federal regulations governing research with humans and/or animals, grant and manuscript preparation, and strategies to succeed in academia. Our curriculum includes a structured timeline to transition to ?K?-series NIH awards, and if needed, our department extends support to assist trainees in this transition. Our NIH T32-supported UW-PID-FP has trained 94 fellows since 1981, with a consistent record of developing research leaders in Maternal-Child Health (Figure 1). During the past 15 years, 34 fellows have successfully completed our TP, 1 transferred to a different TP, and 9 are current fellows. As of May 2017, of the 34 TP graduates from the past 15 years, 18 (53%) have been awarded Ks. Of the graduates completing our TP more than 5 years ago (and therefore at the stage one would progress to NIH R-level funding), 11/26 (42%) have received Rs. Biomedical research continues to be a primary focus of 26/34 (76%) graduates from the last 15 years: 17 lead academic labs (PIs of R, K or foundation grants), 2 are academic research scientists, 4 are lead researchers within government institutions with intramural funds, 1 is an industry researcher, and 2 are university biology professors teaching undergraduates and performing research. The remaining 8/34 (24%) include: 2 clinician educators at academic hospitals where they participate in research, and 6 clinical specialists in infectious diseases. We have 9 current fellows and 1 new fellow entering in July 2017; 8 of these have submitted ?1 individual applications for K and/or foundation grants; 4 received awards, and 6 have pending applications. Among our current fellows and recent graduates (N=43) from the past 15 years, 6 (14%) are under-represented-minorities (URM) in health sciences. In 2017, two fellows will complete their 3rd year of fellowship and both will continue as 4th-year Senior Fellows/Instructors with funding by our department or their pending K and/or other grant applications; 2 others will complete their 4th-year of fellowship, one joining Georgetown University as an Assistant Professor and the other currently deciding between 3 university offers.

Public Health Relevance

Academic researchers focused on infectious diseases have contributed to the elimination, prevention and control of diverse infections that cause substantial morbidity and mortality in children, including smallpox, polio, meningitis, measles, malaria, diarrhea, and AIDS. Despite substantial progress, long-standing and emerging infectious diseases remain the leading causes of death and disability to children in the US and globally, especially among children under 5 years of age. The goal of this proposal is to train committed individuals to perform needed and groundbreaking research on the prevention and treatment of infections that afflict children, and to enable these researchers to focus their careers on improving the health of children everywhere.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Institutional National Research Service Award (T32)
Project #
2T32HD007233-36A1
Application #
9490672
Study Section
Special Emphasis Panel (ZHD1)
Program Officer
Higgins, Rosemary
Project Start
1981-07-01
Project End
2023-04-30
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
36
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98101
Hernandez, Rafael E; Galitan, Louie; Cameron, James et al. (2018) Delay of Initial Feeding of Zebrafish Larvae Until 8 Days Postfertilization Has No Impact on Survival or Growth Through the Juvenile Stage. Zebrafish 15:515-518
Adams Waldorf, Kristina M; Nelson, Branden R; Stencel-Baerenwald, Jennifer E et al. (2018) Congenital Zika virus infection as a silent pathology with loss of neurogenic output in the fetal brain. Nat Med 24:368-374
Gern, Benjamin H; Greninger, Alexander L; Weissman, Scott J et al. (2018) Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus. Ann Clin Microbiol Antimicrob 17:5
Cohen, Sara B; Gern, Benjamin H; Delahaye, Jared L et al. (2018) Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination. Cell Host Microbe 24:439-446.e4
Vornhagen, Jay; Armistead, Blair; Santana-Ufret, VerĂ³nica et al. (2018) Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection. J Clin Invest 128:1985-1999
Gendrin, Claire; Shubin, Nicholas J; Boldenow, Erica et al. (2018) Mast cell chymase decreases the severity of group B Streptococcus infections. J Allergy Clin Immunol 142:120-129.e6
Harrington, Whitney E; Kanaan, Sami B; Muehlenbachs, Atis et al. (2017) Maternal Microchimerism Predicts Increased Infection but Decreased Disease due to Plasmodium falciparum During Early Childhood. J Infect Dis 215:1445-1451
Kanaan, Sami B; Gammill, Hilary S; Harrington, Whitney E et al. (2017) Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant. Oncoimmunology 6:e1311436
Kanthula, Ruth; Rossouw, Theresa M; Feucht, Ute D et al. (2017) Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission. AIDS 31:1143-1148
Gammill, H S; Harrington, W E (2017) Microchimerism: Defining and redefining the prepregnancy context - A review. Placenta 60:130-133

Showing the most recent 10 out of 66 publications